European Drug Prevention Quality Standards (EDPQS) – Achieving QUALITY in Drug Prevention

Project updates and other news

New video available: Harr...

In December 2015, the United Nations Office on Drugs and Crime (UNODC) held a... Read more

Toolkit 1 (Funding &...

We are pleased to announce that EDPQS Toolkit 1 is now also available in Greek.... Read more

Public Health England run...

In December 2015, Public Health England (PHE) used the EDPQS Training Toolkit... Read more
View all updates Sign up for regular updates

Project summary

The European Drug Prevention Quality Standards (‘Prevention Standards’) represent the work of the European Prevention Standards Partnership, working in close co-operation with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The aim of this work is to provide guidance and support to those working in the European drug prevention community and to promote awareness and application of high quality policy and practice.

Phase I of this work was completed in 2010 under the project name “European standards in evidence for drug prevention”. The resulting Prevention Standards were published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in 2011.

Phase II entitled "Promoting Excellence in Drug Prevention in the EU – Phase II of the European Drug Prevention Quality Standards Project” began in April 2013 and was a 2 year initiative of the Partnership that ended in April 2015 with the publication of practical tools for decision-makers, practitioners and others working in drug prevention. The project was co-funded by the European Union under the European Commission’s DG Justice “Drug Prevention and Information Programme” (DPIP).

The European Drug Prevention Quality Standards support the EU minimum quality standards in drug demand reduction endorsed by the Council of the European Union in September 2015.

The Prevention Standards Partnership in Phase II

Co-beneficiaries

  • Liverpool John Moores University (LJMU), United Kingdom
    (Project lead)
  • Institut Suchtprävention, pro mente Oberösterreich, Austria
  • Charles University Prague (CUNI), Czech Republic
  • Observatoire français des drogues et des toxicomanies (OFDT), France
  • University Mental Health Research Institute (UMHRI), Greece
  • Eötvös Loránd University, Hungary
  • Azienda Sanitaria Locale Milano (ASL Milano), Italy
  • Azienda Sanitaria Locale 2 – Savonese (ASL 2 Savonese), Italy
  • Mazowieckie Centrum Polityki Społecznej (MCPS), Poland

Associate partners

  • United Nations Office on Drugs and Crime (UNODC)
  • Gesundheit Österreich GmbH, Austria
  • University Hospital Heidelberg (REBOUND), Germany
  • National Bureau for Drug Prevention (NBDP), Poland
  • Delegacion del Gobierno para el Plan Nacional sobre Drogas, Spain
  • Social Development Unit, Social Services Administration, Stockholm, Sweden

Project advisors

  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Co-beneficiaries

Liverpool John Moores University (LJMU), United Kingdom
Institut Suchtprävention, pro mente Oberösterreich, Austria
Charles University Prague (CUNI), Czech Republic
Observatoire français des drogues et des toxicomanies (OFDT), France
Eötvös Loránd University, Hungary
University Mental Health Research Institute (UMHRI), Greece
Azienda Sanitaria Locale Milano (ASL Milano), Italy
Azienda Sanitaria Locale 2 – Savonese (ASL 2 Savonese), Italy
Mazowieckie Centrum Polityki Społecznej (MCPS), Poland

Associate partners

United Nations Office on Drugs and Crime (UNODC)
Gesundheit Österreich GmbH, Austria
University Hospital Heidelberg(REBOUND)
National Bureau for Drug Prevention (NBDP), Poland
Delegacion del Gobierno para el Plan Nacional sobre Drogas, Spain
Social Development Unit, Social Services Administration, Stockholm, Sweden

Project advisors

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Meet the Partnership